The Medicines Company (MDCO): Price and Financial Metrics


The Medicines Company (MDCO)

Today's Latest Price: $84.90 USD

0.06 (-0.07%)

Updated Jan 3 6:55pm

Add MDCO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

See all "A" rated Strong Buy stocks

MDCO Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for MDCO is -0.09 -- better than only 6.73% of US stocks.
  • MDCO's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 0.54% of US stocks.
  • Revenue growth over the past 12 months for Medicines Co comes in at -129.28%, a number that bests only 0.45% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to MDCO, based on their financial statements, market capitalization, and price volatility, are ABEO, MBIO, SYNA, JNCE, and ADAP.
  • MDCO's SEC filings can be seen here. And to visit Medicines Co's official web site, go to www.themedicinescompany.com.
MDCO Daily Price Range
MDCO 52-Week Price Range

MDCO Stock Price Chart More Charts


MDCO Price/Volume Stats

Current price $84.90 52-week high $84.98
Prev. close $84.96 52-week low $17.81
Day low $84.88 Volume 15,594,699
Day high $84.98 Avg. volume 9,546,600
50-day MA $71.86 Dividend yield N/A
200-day MA $46.19 Market Cap 6.77B

The Medicines Company (MDCO) Company Bio


The Medicines Company is a provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company was founded in 1996 and is based in Parsippany, New Jersey.





MDCO Latest News Stream


Event/Time News Detail
Loading, please wait...

MDCO Latest Social Stream


Loading social stream, please wait...

View Full MDCO Social Stream

MDCO Price Returns

1-mo 0.26%
3-mo 51.23%
6-mo 129.83%
1-year 330.75%
3-year 139.36%
5-year 198.94%
YTD -0.05%
2019 343.78%
2018 -29.99%
2017 -19.45%
2016 -9.11%
2015 34.95%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5887 seconds.